Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Future Oncology (London, England)|February 23, 2019
Sequential therapy with ramucirumab and/or checkpoint inhibitors for non-small-cell lung cancer in routine practiceCliff Molife, Lisa M Hess, Zhanglin Lin Cui, et al.JMIR Research Protocols|October 13, 2017
Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study ProtocolLisa M Hess, David M Kern, Gebra Cuyun Carter, et al.Leukemia & Lymphoma|September 18, 2008
Clinical and pathological prognostic markers for survival in adult patients with post-transplant lymphoproliferative disorders in solid transplantAna B Oton, Hong Wang, Xavier Leleu, et al.Clinical and Translational Science|April 19, 2011
Significant downregulation of platelet gene expression in metastatic lung cancerDavid C Calverley, Tzu L Phang, Qamrul G Choudhury, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results databaseTaofeek K Owonikoko, Camille C Ragin, Chandra P Belani, et al.Cancer|April 11, 2012
Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancerAndrew J Weickhardt, Micol S Rothman, Smita Salian-Mehta, et al.Cancer|May 4, 2024
Onset and resolution of ovarian toxicity with nirogacestat treatment in females with desmoid tumors: Updated safety analyses from the DeFi phase 3 studyElizabeth T Loggers, Rashmi Chugh, Noah Federman, et al.ESMO Open|November 16, 2016
Cancer clinical research in Latin America: current situation and opportunities. Expert opinion from the first ESMO workshop on clinical trials, Lima, 2015Christian Rolfo, Christian Caglevic, Denisse Bretel, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 22, 2011
Anaplastic lymphoma kinase gene rearrangements in non-small cell lung cancer are associated with prolonged progression-free survival on pemetrexedD Ross Camidge, Scott A Kono, Xian Lu, et al.Clinical Lung Cancer|May 9, 2017
Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III StudiesCorey J Langer, Luis G Paz-Ares, Antoinette J Wozniak, et al.Pageof 3